Get started
Author

Michael LoPresti

Observed names: LoPresti, Michael, M LoPresti, M. LoPresti, M. Lopresti, Michael Goddard LoPresti, Michael Lopresti
ORCID: 0000-0002-2389-8218
Observed ORCID: 0000-0002-2389-8218
OpenAlex ID: A5103039984
Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review
2020 · Akira Yuasa, Naohiro Yonemoto, et al. · PharmacoEconomics · 41
PDF
Cost–utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan
2016 · Ataru Igarashi, Wentao Tang, et al. · Current Medical Research and Opinion · 29
Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review
2021 · Akira Yuasa, Naohiro Yonemoto, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 23
PDF
Prevalence, Incidence, and Clinical Characteristics of Thyroid Eye Disease in Japan
2023 · Natsuko Watanabe, Ai Kozaki, et al. · Journal of the Endocrine Society · 22
PDF
A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan
2024 · Michael LoPresti, Ataru Igarashi, et al. · Epilepsy & Behavior · 19
PDF
A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria
2022 · Atsuyuki Igarashi, Akira Yuasa, et al. · Dermatology and Therapy · 19
PDF
The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan
2024 · Michael LoPresti, Ataru Igarashi, et al. · Epilepsy & Behavior · 18
Cost–utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan
2016 · Ataru Igarashi, Wentao Tang, et al. · Current Medical Research and Opinion · 18
Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders
2022 · Akira Yuasa, Naohiro Yonemoto, et al. · Advances in Therapy · 12
PDF
Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers
2022 · Manabu Akazawa, Daisuke Shima, et al. · Patient Preference and Adherence · 8
PDF
Value-based reimbursement under the inpatient prospective payment system in Japan: a review of Japan’s diagnosis procedure combination/per-diem payment system
2024 · Michael LoPresti, Ataru Igarashi · Journal of Medical Economics · 7
Factors Related to Treatment Non-Adherence Among Caregivers of Pediatric and Adolescent Growth Hormone Deficiency Patients in Japan
2024 · Manabu Akazawa, Takahiro Sato, et al. · Patient Preference and Adherence · 6
PDF
Cost-Utility Analysis Of Sofosbuvir For Treatment Of Genotype2 Chronic Hepatitis C In Japan
2014 · A. Igarashi, W. Tang, et al. · Value in Health · 6
PDF
Systematic Literature Review of Clinical Outcomes in Adults with Metastatic or Advanced Synovial Sarcoma
2020 · Kentaro Kogushi, Michael LoPresti, et al. · Future Oncology · 4
Willingness to Pay for Treatment Attributes in Diffuse Large B-Cell Lymphoma: A Discrete Choice Experiment in Japan
2026 · Yasuyuki Arai, Timothy Bolt, et al. · Clinical Drug Investigation · 3
PDF
The relationship between cost and the recommendation, refusal, and discontinuation of treatment for chronic myeloid leukemia and multiple myeloma in Japan: a cross-sectional exploratory survey
2022 · Taro Munakata, Yutaka Handa, et al. · Journal of Medical Economics · 3
Risk attitudes and value of hope: survey results from Japanese hematologists and oncologists treating patients with diffuse large B-cell lymphoma
2026 · Yasuyuki Arai, Timothy Bolt, et al. · Scientific Reports · 2
PDF
Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment
2025 · Daisuke Nakamoto, Yi Piao, et al. · Journal of Medical Economics · 2
A pragmatic review of cost-effectiveness evaluations of reimbursed medical devices conducted for Japan
2024 · Michael LoPresti, Ataru Igarashi · Journal of Medical Economics · 2
PDF
Identifying and Addressing Knowledge and Confidence Gaps Regarding the Management of Patients with Sickle Cell Disease Via Engaging Continuing Medical Education
2023 · Katie Robinson, Robert A. Esgro, et al. · Blood · 1
Review of Real-World Databases in Japan and South Korea That Could be Used to Inform Healthcare Resource Use and Cost Inputs for Health Economic Studies
2018 · D Mazumder, H Bhandari, et al. · Value in Health · 1
Japanese hematologists’ and oncologists’ perceptions of patient preferences for shared decision-making
2026 · Yasuyuki Arai, Timothy Bolt, et al. · BMC Research Notes
PCR132 Impact of Shared Treatment Decision Making Between Physicians and Patients on Treatment Satisfaction in Hypertension
2025 · Yaoki Sonohara, Ryosuke Nishi, et al. · Value in Health
Willingness to pay for DLBCL treatment characteristics in Japan
2025 · Yasuyuki Arai, Timothy Bolt, et al. · Blood
PDF
Development and validation of the Delirium Burden Scale for Healthcare Providers (DBS‐HCP)
2025 · Naoya Ueda, Ichiro Tazaki, et al. · Psychiatry and Clinical Neurosciences Reports
PDF
Works count: 43
Citation count: 246
H-index: 9
I10-index: 9
Year
Topic
Type